CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells. [electronic resource]

By: Contributor(s): Producer: 20191025Description: 116 p. digitalISSN:
  • 2051-1426
Subject(s): Online resources: In: Journal for immunotherapy of cancer vol. 6
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.